# Severence MacLaughlin

> Severence MacLaughlin is the founder and CEO of DeLorean Artificial Intelligence, a Palm Beach-based company building predictive AI products for healthcare and sales. A Cornell-trained scientist with a PhD from the University of Adelaide, he ran AI and data science practices at Cognizant and Capgemini Invent before bootstrapping DeLorean AI with his own savings. The company says its Medical AI was the first to be biologically validated by two independent laboratories, trained on tens of millions of patient records and backed by seven patents. He advises the United Nations and World Health Organization on AI.

- **Role:** CEO & Founder at DeLorean Artificial Intelligence
- **Organizations:** DeLorean Artificial Intelligence, Capgemini Invent, Cognizant Technology Solutions, MacLaughlin Global, American Red Cross
- **From:** Rhode Island, United States
- **Nationality:** American
- **Education:** B.S. Animal Science (Reproductive Physiology), Cornell University, Ph.D., Embryonic and Fetal Development, University of Adelaide
- **Known for:** Founded and bootstrapped DeLorean Artificial Intelligence with his own savings, Built Medical AI, described as the first AI biologically validated by two independent laboratories, Models trained on more than 80 million patient records, backed by seven patents

## Career timeline

- **2000** — Graduated from Cornell University with a B.S. in Animal Science
- **2006** — Completed Ph.D. in Australia working with large mainframe datasets
- **2009** — Founded a strategic analytics practice within a consulting firm
- **2015** — Founded MacLaughlin Global
- **2016** — Became Global Head of AI for Healthcare & Life Sciences at Cognizant
- **2018** — Became Chief of Intelligence for the Western Hemisphere at Capgemini Invent
- **2020** — Founded DeLorean Artificial Intelligence
- **2023** — DeLorean AI raised a Series A (reported $7.5M)

## Achievements

- Founded and bootstrapped DeLorean Artificial Intelligence with his own savings
- Built Medical AI, described as the first AI biologically validated by two independent laboratories
- Models trained on more than 80 million patient records, backed by seven patents
- Ranked among the top-ranked life sciences and healthcare data scientists globally
- Recognized as an American Healthcare Leader (Q1 2018)
- Current advisor to the United Nations and World Health Organization on AI
- Appeared on Nasdaq TradeTalks to discuss predictive AI in healthcare

## Latest updates

- **2025-04** — Featured in a VENSEARCH video interview on revolutionizing healthcare with predictive AI.
- **2025-11** — Shared on LinkedIn how DeLorean AI is being applied to kidney disease care.

## Links

- Website: https://deloreanai.com
- LinkedIn: https://www.linkedin.com/in/severence-maclaughlin-ph-d-a759475
- Twitter/X: https://twitter.com/deloreanai/
- YouTube: https://www.youtube.com/watch?v=RyTxz45PpqY

---

Profile page: https://yespress.io/severence-maclaughlin
Published by YesPress — https://yespress.io
Last updated: 2026-06-05